RecruitingNCT06017518

An Observational Study of Local Relapse After High Grade Osteosarcoma


Sponsor

Istituto Ortopedico Rizzoli

Enrollment

150 participants

Start Date

Jun 13, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

multicenter retrospective and prospective study in patients with high-grade osteosarcoma


Eligibility

Plain Language Summary

Simplified for easier understanding

This observational study collects data on patients with high-grade osteosarcoma (a type of bone cancer) whose cancer came back in the same location after treatment, in order to better understand what happens and what affects survival. **You may be eligible if...** - You had localized high-grade bone osteosarcoma and your cancer came back in the same location (local relapse) as the first sign of recurrence - You are able to attend follow-up visits - You are willing to provide written consent - There is no age limit **You may NOT be eligible if...** - Your local relapse happened more than 3 months after cancer had already spread to other sites - You are unable to reliably attend follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

IRCCS Istituto Ortopedico Rizzoli

Bologna, BO, Italy

Azienda Ospedaliero-Universitaria Pisana

Pisa, PI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06017518


Related Trials